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CD1d-restricted lymphocytes contribute to anti-
microbial host responses in bacterial, parasitic, 
viral, and fungal infections and to the natural anti-
tumor response (1). Broad specifi  city of CD1d-
restricted T cells is the result of the ability of 
CD1d molecules to bind a range of lipids (1, 2). 
More recently, it has been shown that mouse 
and human NKT cells can also recognize bacteria-
derived diacylglycerol (3), thus demonstrating the 
ability of NKT cells to recognize glycolipids as 
well as glycosphingolipids (GSLs). The ability of 
CD1d-restricted lymphocytes to recognize a 
broad range of self and nonself lipids highlights 
the importance of understanding the parameters 
controlling both their activation in vivo and the 
mechanisms by which the cross-reactivity of lipid-
specifi  c CD1d-restricted T cells is minimized.
The antigen-binding site of mouse and hu-
man CD1d (hCD1d) molecules is composed 
of two channels: A′ and F′ channels in mouse 
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CD1d-restricted lymphocytes recognize a broad lipid range. However, how CD1d-restricted lym-
phocytes translate T cell receptor (TCR) recognition of lipids with similar group heads into dis-
tinct biological responses remains unclear. Using a soluble invariant NKT (iNKT) TCR and a newly 
engineered antibody specifi  c for 𝗂-galactosylceramide (𝗂-GalCer)–human CD1d (hCD1d) com-
plexes, we measured the affi  nity of binding of iNKT TCR to hCD1d molecules loaded with a panel 
of 𝗂-GalCer analogues and assessed the rate of dissociation of 𝗂-GalCer and 𝗂-GalCer analogues 
from hCD1d molecules. We extended this analysis by studying iNKT cell synapse formation and 
iNKT cell activation by the same panel of 𝗂-GalCer analogues. Our results indicate the unique 
role of the lipid chain occupying the hCD1d F′ channel in modulating TCR binding affi  nity to 
hCD1d–lipid complexes, the formation of stable immunological synapse, and cell activation. 
These data are consistent with previously described conformational changes between empty and 
loaded hCD1d molecules (Koch, M., V.S. Stronge, D. Shepherd, S.D. Gadola, B. Mathew, G. Ritter, 
A.R. Fersht, G.S. Besra, R.R. Schmidt, E.Y. Jones, and V. Cerundolo. 2005. Nat. Immunol 6:819–
826), suggesting that incomplete occupation of the hCD1d F′ channel results in conforma-
tional differences at the TCR recognition surface. This indirect effect provides a general 
mechanism by which lipid-specifi  c lymphocytes are capable of recognizing both the group 
head and the length of lipid antigens, ensuring greater specifi  city of antigen recognition.
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CD1d, which connect directly to the surface. For consistency 
with the mouse CD1d literature, the phytosphingosine 
chain–binding channel in hCD1d, which is referred to as 
the C′ channel by Koch et al. (4), is here referred to as the F′ 
channel (5–9). Although the A′ channel can accommodate 
an alkyl chain up to 26 carbon atoms long, the F′ channel can 
accommodate an alkyl chain up to 18 carbon atoms long. 
hCD1d molecules in which the A′ and F′ channels are not 
fi  lled (i.e., that are in the nonlipid-bound state) have a diff  er-
ent conformation than hCD1d molecules bound to α-galac-
tosylceramide (α-GalCer; reference 4). Whereas the entrance 
of the cavity is wider in the empty conformation, the vol-
umes of the A′ and F′ channels are reduced, mostly as a result 
of the conformational shifts in the side chains of several tryp-
tophan residues. The recently solved crystal structures of 
CD1d–α-GalCer–specifi  c TCR and docking models (10, 11) 
are consistent with the TCR binding footprint   encompassing 
the polar head of the lipid ligand and portions of the CD1d 
α1 and α2 helices but do not support direct interactions 
between the TCR and the lipid alkyl chains.
The knowledge derived from the structure of CD1d–α-
GalCer–specifi  c TCRs and from the structure of empty and 
α-GalCer–loaded hCD1d molecules prompted us to carry 
out a series of kinetic and functional experiments to assess the 
role of the length of each alkyl chain in controlling the rate 
of dissociation of lipids bound to hCD1d molecules and the 
affi   nity of binding of lipid-specifi  c TCR. An important pa-
rameter to consider in evaluating the biological eff  ects of 
NKT agonists is the affi   nity of TCR binding to the  glycolipid–
CD1d complex and the stability of glycolipid ligands bound 
to CD1d molecules. It has been shown that the compound 
OCH, which is an analogue of α-GalCer with a truncated 
sphingosine chain, binds less stably to CD1d compared with 
α-GalCer, resulting in a less sustained TCR stimulation and 
secretion of higher amounts of IL-4 than IFN-γ by NKT 
cells (12, 13). To further probe these questions and to address 
the role of lipid length and saturation in infl  uencing CD1d-
restricted T cell responses, we engineered a soluble TCR 
from an invariant NKT (iNKT) cell clone and an antibody 
specifi  c for the hCD1d–α-GalCer complex. Using these two 
reagents, we performed combined kinetic and functional 
studies to compare the affi   nity of TCR binding to hCD1d 
molecules loaded with either α-GalCer or analogues of 
α-GalCer with truncated acyl and phytosphingosine chains. In 
this set of analogues, we included OCH9, which has a shorter 
phytosphingosine chain than α-GalCer and diff  ers from the 
previously described OCH by the addition of two methylene 
groups on the acyl chain (12, 13). We also assessed whether 
Figure 1.  Glycolipids used in this study. The lengths of acyl and phytosphingosine chains are indicated.JEM VOL. 204, May 14, 2007  1133
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the presence of unsaturated double bonds in the acyl chains 
could aff  ect the rate of lipid dissociation from hCD1d mole-
cules and the affi   nity of TCR binding to hCD1d–glycolipid 
complexes. We extended these results by assessing both the 
immunological synapse and lymphokine profi  le of human 
iNKT cells stimulated with the same panel of glycolipids.
The results of these experiments demonstrated that al-
though the length of both phytosphingosine and acyl chains 
controls the stability of lipids bound to hCD1d molecules, the 
length of the phytosphingosine chain, but not the length 
and saturation of the acyl chain, controls the affi   nity of TCR 
binding to hCD1d–glycolipid complexes and iNKT cell acti-
vation. We propose a model involving the propagation of 
conformational changes from within the binding groove to 
the surface that is consistent with the observed eff  ects on TCR 
binding. Because natural lipids have a broad range of acyl chain 
lengths (14), our results are of general importance, as they sug-
gest a mechanism by which lipid-specifi  c lymphocytes can dis-
tinguish individual lipids based on both the headgroup and the 
length of the lipid chain occupying the CD1d F′ channel.
RESULTS
The length of the phytosphingosine chain modulates iNKT 
TCR binding affi  nity to the hCD1d–GSL complex
We refolded hCD1d with a range of α-GalCer analogues 
with truncated acyl or phytosphingosine chains (Fig. 1). We 
then analyzed the rate of dissociation of each GSL from 
hCD1d molecules (Fig. 2 A) and the kinetics of iNKT TCR 
binding to each hCD1d–GSL monomer (Fig. 2 B). To mea-
sure the dissociation of each GSL from hCD1d molecules, 
we generated by phage display library a Fab antibody specifi  c 
for hCD1d molecules loaded with α-GalCer (hereafter re-
ferred to as Fab 9B; unpublished data). Initial surface plasmon 
resonance (SPR) measurements and FACS staining of lipid-
pulsed C1R-hCD1d cells demonstrated that Fab 9B specifi  -
cally recognized hCD1d molecules loaded with the GSL 
shown in Fig. 1, whereas it failed to stain either unpulsed 
C1R-hCD1d cells or C1R-hCD1d cells pulsed with β-GalCer 
(unpublished data). Using Fab 9B, we measured the GSL 
dissociation from soluble hCD1d molecules over time using 
SPR (Fig. 2 A). We observed that shortening either the acyl 
chain or the phytosphingosine chain increased the rate of 
lipid dissociation from hCD1d molecules (Fig. 2 A). Interest-
ingly, the rate of dissociation of compound C20:0 is 2.15-
fold faster than that of compound C20:2 (half-life of 170 min 
and 367 min, respectively, at 25°C), demonstrating that un-
saturation of bonds at carbons 11 and 14 of the acyl chain 
  favors the formation of more stable hCD1d–GSL complexes.
We then assessed whether the length of the acyl and phy-
tosphingosine chains could aff  ect the affi   nity of iNKT TCR 
binding to the hCD1d–GSL complex. We refolded Vα24 
and Vβ11 chains of iNKT TCR as previously described (10) 
and used the purifi  ed and refolded iNKT TCR in SPR stud-
ies against immobilized biotinylated hCD1d–GSL monomers. 
We demonstrated that the affi   nity of iNKT TCR for hCD1d–
α-GalCer was substantially higher than that of hCD1d–
OCH9 (Kd of 1.6 μM compared with 122 μM; Fig. 2 B).
To further understand the contribution of phytosphingo-
sine chain length to the iNKT cell TCR affi   nity, we com-
pared the affi   nity of iNKT TCR binding to hCD1d–OCH9 
complexes with that of hCD1d molecules loaded either with 
OCH12 or OCH15 (Fig. 2 B, bottom). These experiments 
demonstrated that increasing the phytosphingosine chain 
length from 9 to 15 carbons increased the iNKT TCR bind-
ing affi   nity, suggesting that optimal iNKT TCR binding re-
quires the lipid chain occupying the hCD1d F′ channel to 
range from 15 to 18 carbons. In contrast, the length and satu-
ration of the fatty acid chain did not substantially alter the 
iNKT TCR binding affi   nity (Fig. 2 B, middle). Analysis of the 
binding of the anti-β2M antibody (BBM.1) confi  rmed that 
equivalent amounts of correctly refolded hCD1d–ligand 
complexes were immobilized to each sensor surface (unpub-
lished data). As a further control, we showed that diff  erences 
in the iNKT TCR binding affi   nity were not the result of dif-
ferences in loading of hCD1d monomers with α-GalCer, 
OCH12, and OCH9 (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20062342/DC1). The rate con-
stants (kon and koff  ) of iNKT TCR binding were measured 
  directly for all hCD1d–GSL complexes with the exception of 
hCD1d–OCH9, in which the exceptionally fast koff   made 
Table I.  Affi  nity and kinetics measurements
hCD1d–GSL 
complex
Kd koff kon kon
μMS −1 M−1S−1 M−1S−1
α-GalCer 1.29 ± 0.08a 0.39 ± 0.01a 3.31 × 105 ± 2.5 × 104a 3.10 × 105 ± 4.0 × 104a
C20:0 2.73 ± 0.69a 0.58 ± 0.07 2.38 × 105 ± 4.6 × 104 2.13 × 105 ± 1.9 × 104
C20:2 1.83 ± 0.13a 0.46 ± 0.06 2.46 × 105 ± 2.3 × 104 2.49 × 105 ± 1.1 × 104
C11:1 3.40 ± 0.39a 0.59 ± 0.04 1.65 × 105 ± 3.5 × 104 1.75 × 105 ± 2.6 × 104
OCH15 2.50 ± 0.36a 0.47 ± 0.06 2.04 × 105 ± 1.6 × 104 1.92 × 105 ± 2.5 × 104
OCH12 23.3 ± 1.41a 1.00 ± 0.12 3.7 × 104 ± 5 × 103 4.3 × 104 ± 6 × 103
OCH9 123 ± 9.08a 2.67 ± 0.12a ND 2.3 × 104 ± 1 × 103
All values are the mean of two experiments except where otherwise noted. The kon values were experimentally determined by SPR except those in the last column, which were 
calculated from the experimentally determined koff and Kd values.
aMean of three or more experiments.1134  NKT CELLS SENSE THE LENGTH OF LIPIDS BOUND TO CD1D | McCarthy et al.
direct determination of the kon diffi   cult. Nevertheless, it was 
possible to calculate kon for iNKT TCR binding to hCD1d–
OCH9 from the Kd and koff   (Table I). Comparison of the 
binding kinetics of iNKT TCR to the hCD1d–GSL mono-
mers demonstrated that the decrease in affi   nity observed with 
shortening the phytosphingosine chain was as much the result 
of decreases in the kon as increases in the koff   (Fig. 2 B and 
  Table I). Agreement was observed between the affi   nities calcu-
lated from the kinetic constants and the affi   nities determined 
by equilibrium binding (Table I and unpublished data).
To ensure that diff  erences in the affi   nity of iNKT TCR 
binding to hCD1d–GSL complexes were physiologically 
Figure 2.  Affi  nity and kinetics of GSL binding to hCD1d and iNKT 
TCR binding to the hCD1d–GSL complex. (A) Dissociation of GSL from 
hCD1d. The indicated hCD1d–GSL complex was loaded onto a sensor sur-
face at t = 0, and the amount of hCD1d remaining at the indicated time 
point was measured using Fab 9B. (B) Affi  nity and kinetics of iNKT TCR 
binding to hCD1d complexed with α-GalCer (top), C20:0, C20:2, and C11:1 
(middle), and OCH15, OCH12, and OCH9 (bottom). Increasing concentra-
tions from 0.4 to 194 μM (twofold dilution) of iNKT TCR were injected for 
5 s over the indicated hCD1d–GSL complexes. The binding responses of 
fi  ve concentrations are shown superimposed. The insets show binding 
response at equilibrium. A representative experiment is shown. (C) C1R-
hCD1d cells were pulsed with the GSLs shown and were stained with the 
biotinylated tetramerized iNKT TCR. Mean channel fl  uorescence (MCF) as 
determined by FACS is shown to vary with the TCR affi  nity as measured 
by SPR studies. A representative experiment out of three is shown.JEM VOL. 204, May 14, 2007  1135
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relevant, we used biotinylated iNKT TCR to stain C1R-
hCD1d cells pulsed with a panel of GSL (Fig. 2 C). The 
results of these experiments confi  rmed that C1R-hCD1d 
cells pulsed with α-GalCer and OCH15 were stained more 
effi   ciently than C1R-hCD1d pulsed with either OCH12 or 
OCH9 (Fig. 2 C). As a control, GSL-pulsed C1R-hCD1d 
cells were stained with the Fab 9B antibody to ensure a simi-
lar loading of hCD1d molecules by the panel of GSL at a 
concentration of 10 μg/ml (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20062342/DC1).
iNKT cells form classical immunological synapses in response 
to hCD1d–GSL complexes
To extend our fi  ndings on the molecular aspects of the iNKT 
cell immunological synapse and to investigate the possibility that 
diff  erences in iNKT TCR affi   nity for the various hCD1d–GSL 
Figure 3.  Kinetics and threshold of human iNKT cell synapse for-
mation. (A) Time lapse of the interaction of an iNKT cell with an artifi  cial 
lipid bilayer loaded with hCD1d–α-GalCer antigen at a density of 200 
molecules/μm2 (green) and ICAM-1 at a density of 80 molecules/μm2 
(red) as visualized by confocal microscopy. Contacts of the iNKT cell with 
the bilayer were visualized by IRM (grayscale, bottom). (B and C) The 
amount of hCD1d–ligand (B) and ICAM-1 (C) aggregated were quantifi  ed 
as a function of time for hCD1d–α-GalCer (closed circles) and hCD1d–
OCH9 (open circles). All of the data is representative of at least 20 cells in 
three independent experiments. Loading of lipid bilayers with either 
hCD1d–α-GalCer or hCD1d–OCH9 monomers was normalized using 
Fab 9B, confi  rming a similar proportion of hCD1d monomers containing 
α-GalCer and OCH9 within the duration of each experiment. (D) The 
amount of antigen aggregated was quantifi  ed for the different ligands and 
densities as a function of time. ICAM-1 accumulation levels were equivalent 
in all of the cases (not depicted). (E) Synapse formation for the indicated 
ligands (α-GalCer, OCH9, C20:0, and β-GalCer) displayed at varying den-
sities (top number in molecules/μm2) in the presence of ICAM-1 (density = 
80 molecules/μm2) as visualized by confocal microscopy. A representative 
single cell after 30 min of interaction with the bilayer is shown in each 
column. Bars, 5 μm.1136  NKT CELLS SENSE THE LENGTH OF LIPIDS BOUND TO CD1D | McCarthy et al.
complexes may have an eff  ect on the kinetics and/or pattern 
of hCD1d accumulation during synapse formation, we quan-
tifi  ed the segregation and accumulation of hCD1d molecules 
and ICAM-1 in real time.
To this end, iNKT cells, from which the TCR for the 
kinetic studies was cloned, were settled onto bilayers contain-
ing AlexaFluor542-conjugated glycosyl-phosphatidylinositol 
(GPI)–linked ICAM-1 and biotinylated hCD1d monomers 
loaded with either α-GalCer or OCH9, which showed the 
greatest disparity in iNKT TCR affi   nity. We then followed 
the pattern of ICAM-1 (Fig. 3 A, red) and hCD1d (Fig. 3 A, 
green) distribution over time by confocal microscopy and 
correlated it with iNKT cell contact with the membrane as 
assessed by interference refl  ection microscopy (IRM), which 
allows the visualization of close membrane apposition as dark 
areas (Fig. 3 A).
We demonstrated that both hCD1d–OCH9 and hCD1d–
α-GalCer monomers stimulated the formation of a classic 
immunological synapse, as characterized by the cessation of 
migration (Fig. 3 A and Video 1, available at http://www.jem
.org/cgi/content/full/jem.20062342/DC1), the formation 
of a classic central supramolecular activation cluster (SMAC 
[cSMAC]), and aggregation of ICAM-1 to form a periph-
eral SMAC. This central zone of interaction was bordered by 
a ring of close apposition of the T cell membrane and planar 
bilayer (darkest area of IRM image). In the absence of ICAM-1 
in the lipid bilayer, no clustering of hCD1d–α-GalCer 
molecules was observed (unpublished data). Quantifi  cation of 
the amount of hCD1d–α-GalCer–loaded molecules (Fig. 3 
B) and ICAM-1 (Fig. 3 C) showed that a maximal clustering 
of both molecules was reached within 5 min and a plateau 
after 10 min. In contrast, quantifi  cation of the amounts of 
hCD1d–OCH9-loaded molecules (Fig. 3 B) showed slower 
kinetics and reduced maximal clustering of hCD1d–OCH9 
monomers as compared with hCD1d–α-GalCer. Interest-
ingly, consistent with the evidence that LFA-1 delivers a sig-
nal distinct from that of the TCR, accumulation of ICAM-1 
to the peripheral SMAC was comparable between hCD1d–
α-GalCer– and hCD1d–OCH9-stimulated synapses (Fig. 
3 C). We also demonstrated that although hCD1d monomers 
loaded with β-GalCer did not induce any hCD1d clustering, 
some gathering of ICAM-1 was observed (Fig. 3 E). These 
results are consistent with previously published data analyzing 
the formation of the immunological synapse in T cells (15) 
and indicate that the affi   nity of the iNKT cells for hCD1d–
GSL complexes may play an important role in determining 
ligand recognition.
To determine whether this diff  erence in affi   nity translates 
into diff  erential thresholds of hCD1d–GSL recognition, we 
compared the interaction of iNKT cells with lipid bilayers 
loaded with constant ICAM-1 concentration but decreas-
ing densities of either hCD1d–α-GalCer or hCD1d–OCH9 
monomers (Fig. 3, D and E). These results showed that a 
minimum density of 10 molecules/μm2 was suffi   cient to 
trigger hCD1d–α-GalCer and hCD1d-C20:0 accumulation 
and immunological synapse formation (Fig. 3, D and E). 
In contrast, at this same density of hCD1d–OCH9, iNKT 
cells failed to aggregate antigen or show any sign of syn-
apse formation. Indeed, a 10-fold increase in the density of 
hCD1d–OCH9 was required to observe similar frequen-
cies of synapse formation. Because hCD1d–α-GalCer and 
hCD1d-C20:0 have a similar affi   nity of binding to iNKT 
Figure 4.  Calcium infl  ux in response to the CD1d–ligands. (A) 
Kinetics of calcium infl  ux of iNKT cells in contact with bilayers loaded 
with hCD1d–α-GalCer (top) or hCD1d–OCH9 (bottom) at a density of 200 
molecules/μm2 in the presence of ICAM-1 (density = 80 molecules/μm2) 
as visualized by confocal microscopy. Fluorescence is shown in a pseudo-
color scale. (B) The amount of intracellular calcium infl  ux in fl  uorescence 
units (arbitrary units [AU]) for α-GalCer (closed circles) and OCH9 (open 
circles) quantifi  ed over a period of 10 min. Bars, 5 μm.JEM VOL. 204, May 14, 2007  1137
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TCR (Fig. 2 B) and OCH9 and C20:0 have a similar rate of 
dissociation from hCD1d molecules (Fig. 2 A), these results 
demonstrate that the affi   nity of iNKT TCR determines the 
capacity of iNKT cells to cluster hCD1d–lipid complexes, 
and this may play a role in defi  ning the threshold of iNKT 
cell activation.
Strength of iNKT cell stimulation is determined 
by the dynamics of synapse formation
To establish whether the diff  erential accumulation of hCD1d–
GSL complexes to the synapses correlated with the strength 
of the subsequent iNKT cell activation, we monitored the 
changes in intracellular calcium levels of iNKT cells stimu-
lated with planar bilayers loaded with either hCD1d–α-GalCer 
or hCD1d–OCH9. At the same densities, hCD1d–α-GalCer–
stimulated synapses resulted in a greater and more rapid 
fl  uxing of calcium into the iNKT cells compared with hCD1d–
OCH9-stimulated synapses (Fig. 4, A and B). These results 
further support the concept that the length of the phy-
tosphingosine chain of the lipid antigen is important in deter-
mining the threshold of iNKT cell activation.
To further assess the functional consequences of the diff  er-
ences in CD1d–GSL and TCR binding affi   nities, we analyzed 
the effi   ciency of polarization of iNKT cell lytic granules on 
the stimulation of iNKT cells with C1R- hCD1d target cells 
pulsed with either α-GalCer or OCH9, which are the stron-
gest and weakest iNKT cell agonists, respectively. Titration 
of the lipid concentrations for both α-GalCer and OCH9 
Figure 5.  𝗂-GalCer is effi  cient in inducing the polarization of 
iNKT cell granules at the immunological synapse. (A) The confocal 
images show iNKT cells conjugated with C1R-hCD1d cells pulsed with 
1 μM α-GalCer. Lytic granules are stained with anti–cathepsin D (green) 
and both target and effector cells stained with antitubulin (red). Upon 
target cell recognition, lytic granules move from the rear of the cell (left), 
around the nucleus (middle), and polarize at the immunological synapse 
(right). (B and C) Quantitative analysis of granule polarization in iNKT cells 
recognizing C1R-hCD1d cells pulsed with α-GalCer (B) or OCH9 lipids (C). 
Cell conjugates with granules at the rear (white bars), granules moving 
laterally toward the synapse (gray bars), and granules at the synapse 
(black bars) were counted using a fl  uorescence microscope. (D) iNKT-
dependent lysis of DCs pulsed with either α-GalCer or OCH9. Human 
monocyte-derived DCs were incubated with a human iNKT line at a ratio 
of 1:1 in the presence of different concentrations of α-GalCer (open tri-
angles) or OCH9 (fi  lled squares). After 24 h, DC viability was evaluated by 
FACS analysis gating on propidium iodide–negative cells. Error bars repre-
sent SD.1138  NKT CELLS SENSE THE LENGTH OF LIPIDS BOUND TO CD1D | McCarthy et al.
  revealed that the number of polarized iNKT cells conjugated 
to targets was greatly reduced at lower concentrations of 
OCH9 when compared with α-GalCer (Fig. 5, B and C). 
When C1R-hCD1d cells were pulsed with OCH9, polariza-
tion was poor (i.e., 10 ng/ml OCH was required to see 50% 
of iNKT cell conjugates with tightly polarized granules at the 
synapse). In contrast, 0.001 ng/ml α-GalCer was suffi   cient 
to see 60% of iNKT cell conjugates with tightly polarized 
granules at the synapse. Because the affi   nity of Fab 9B for α-
GalCer–CD1d and OCH9–CD1d monomers is very similar 
(Kd of 408 nM and 595 nM, respectively; unpublished data), 
FACS staining of C1R-hCD1d cells pulsed with 1 μM α-
GalCer and OCH9 with Fab 9B confi  rmed that within the 
time frame of the experiment shown in Fig. 5, the amount of 
α-GalCer and OCH9 presented by C1R-hCD1d cells was 
comparable (not depicted). Consistent with the observed 
slower and less effi   cient polarization of cytotoxic granules of 
iNKT cells activated by OCH9, we demonstrated that human 
DCs pulsed with OCH9 were killed less effi   ciently by iNKT 
cells than human DCs pulsed with α-GalCer (Fig. 5 D).
iNKT cell TCR affi  nity for hCD1d–lipid complexes modulates 
iNKT cell activation
The density of clustered hCD1d–α-GalCer and the 
proportion of cells forming immunological synapses with α-
GalCer as compared with OCH9 correlated with the in vitro 
activation of human iNKT cells as defi  ned by IL-4 and IFN-γ 
secretion (Fig. 6 A). Furthermore, unlike results obtained with 
mouse iNKT cells (13, 16), the cytokine profi  le of human 
iNKT cells stimulated by OCH9 and OCH12 was not biased 
toward a Th2 response; rather, less IL-4 and IFN-γ were se-
creted (Fig. 6 A). Comparable cytokine profi  les were obtained 
using iNKT cells stimulated with α-GalCer and with com-
pounds with truncated acyl chains and OCH15. Thus, the pat-
tern of cytokine production and target cell lysis by iNKT cells 
in response to lipid-pulsed target cells was consistent with the 
diff  erential activation of iNKT cells.
Finally, we demonstrated the ability of both α-GalCer 
and OCH9 to stimulate the expansion of iNKT cells from 
peripheral blood lymphocytes from healthy donors (Fig. 6 B). 
Although α-GalCer was capable of sustaining iNKT cell pro-
liferation at concentrations < 10−11 M, OCH9 failed to in-
duce iNKT cell proliferation at concentrations <10−10 M, 
and, at all concentrations, α-GalCer stimulated greater num-
bers of iNKT cells.
D  I  S  C  U  S  S  I  O  N 
Our results provide important insights into the mechanisms 
controlling lipid-specifi  c T cell responses by demonstrating 
that modifi  cations of the lipid chain buried in the F′ channel 
of hCD1d molecules can modulate the TCR affi   nity, formation 
of stable synapses, and, ultimately, lymphocyte activation. 
Previous studies have established that modifi  cations of the 
alkyl chains may alter the activation of lipid-specifi  c T cells 
(3, 13, 17–21). However, a combined kinetic and functional 
analysis has not been previously performed.
Because α-GalCer has the maximum lipid chain lengths 
that are able to fi  t into the antigen-binding groove of hCD1d 
and there are conformational diff  erences between lipid-bound 
and nonlipid-bound CD1d molecules (4), we reasoned that 
binding of hCD1d molecules with analogues of α-GalCer 
containing shorter lipid chains may result in the partial col-
lapse of unfi  lled portions of the A′ and F′ channels, resulting 
Figure 6.  iNKT cell expansion and activation in vitro is modulated 
by the length of GSL sphyngosine chain. (A) CIR-hCD1d cells were 
pulsed with shown GSL and used to stimulate human iNKT cells. Super-
natant was assayed for IL-4 (gray bars) or IFN-γ (black bars) by ELISA. SD 
from the mean (error bars) of two duplicate assays is shown. (B) iNKT cell 
frequency (Vα24+hCD1d-tetramer+ cells as the percentage of gated cells) 
on day 21 after stimulation of PBLs with mature autologous DCs pulsed 
with either α-GalCer or OCH9 at varying concentrations. Experiments 
were performed three times using three different healthy donors. The 
results of a representative experiment are shown.JEM VOL. 204, May 14, 2007  1139
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in surface-exposed structural changes. This reasoning led us 
to study whether the binding affi   nity of soluble iNKT TCR 
to hCD1d molecules loaded with GSL containing an identi-
cal polar head can be fi  ne tuned by modifying the length of 
the lipid chains.
It has recently been reported that diacylglycerol lipids 
from Borrelia burgdorferi are recognized by iNKT cells and 
that their antigenic potency is dependent on acyl chain 
length and saturation (3). In particular, it was shown that 
mouse iNKT cells more effi   ciently recognize mouse CD1d 
molecules loaded with diacylglycerol analogues with 16-
carbon-long R2 fatty acids. In contrast, human iNKT cells more 
effi   ciently recognize hCD1d molecules loaded with diacyl-
glycerol analogues with 18-carbon-long R2 fatty acids (3). 
It is likely that these diff  erences between human and mouse 
iNKT cells can be accounted for by the shorter length of 
the mouse CD1d F′ channel as compared with the hCD1d 
F′ channel (4–7). However, these results did not address 
whether the enhanced potency of diacylglycerol analogues 
is caused by their more stable binding to CD1d molecules 
or rather to a higher TCR affi   nity. To distinguish between 
these possibilities, we independently analyzed the role of 
lipid chains occupying the A′ and F′ channels in hCD1d 
molecules in modulating the TCR affi   nity and/or stability 
of hCD1d–GSL complexes.
The central claim of this study is that the length of the 
lipid chain occupying the F′ channel modulates the binding 
affi   nity of iNKT TCR. This claim is supported by two com-
plementary experimental systems: (a) SPR, analyzing the 
binding of soluble iNKT TCR to in vitro refolded CD1d 
molecules coated to BIAcore chips (Fig. 2, A and B), and (b) 
FACS staining, analyzing the binding of biotinylated tetra-
merized iNKT TCR to C1R-hCD1d cells pulsed with a 
panel of GSLs (Fig. 2 C).
The diff  erence in TCR binding affi   nity between α-
GalCer, OCH12, and OCH9 could be accounted for by the 
hypothesis that shortening of the phytosphingosine chain 
could cause a repositioning of this lipid chain in the hCD1d 
F′ channel and, thus, directly alter the position of the α-linked 
galactose or cause a shift in the α helices of hCD1d as a result 
of a collapse of the partially unfi  lled F′ channel.
If it is assumed that OCH9 retains the same orientation 
as α-GalCer, a comparison of the crystal structures of α-
GalCer–loaded and empty hCD1d molecules (4) suggests 
that loading hCD1d molecules with OCH9 will only drive 
part of the F′ channel into the fi  lled conformation because of 
the shorter phytosphingosine chain (Fig. 7 A). This modifi  ca-
tion results in predicted diff  erences between hCD1d–OCH9 
and hCD1d–α-GalCer structures of  2 Å in the main chain 
of the α2 helix between residues Leu139 and Thr154. This 
region is at the center of the putative TCR binding footprint 
as mapped by mutagenesis studies (22, 23) and includes two 
residues (Asp151 and Thr154) that hydrogen bond to the 
α-GalCer headgroup. Any substantial alterations in the posi-
tions of these residues may be expected to impact on the hy-
drogen bond network, which dictates the position of the 
headgroup, and, thus, to aff  ect the recognition of α-GalCer 
by iNKT TCR.
These models and our fi  nding that truncating the phyto-
sphingosine chain decreases the kon support a conformational 
change mechanism whereby hCD1d can exist in more than 
one conformation, a subset of which can bind iNKT TCR, 
and fi  lling the F′ channel favors the TCR-binding confor-
mations. A similar modeling exercise to assess the eff  ect of 
shortening the acyl chain (i.e., the structural diff  erences asso-
ciated with incomplete occupation of the A′ channel; Fig. 7 B) 
predicts changes in the position of the α1 helix from residues 
Phe58 to Phe70, but, in contrast to the diff  erences resulting 
from a partially unfi  lled F′ channel, these changes are in a 
  region that is peripheral to the iNKT cell TCR docking area 
and have no infl  uence on the orientation of the α-GalCer 
headgroup. Collectively, these structural considerations con-
cur with our data, which indicate that changes in the length 
of the phytosphingosine but not the acyl chain can modulate 
TCR recognition.
The observation that fatty acid spacers have been identi-
fi  ed in the A′ channel seems to suggest that the presence of 
these short-chain lipids could be a conserved element, ensur-
ing full occupancy of the A′ channel (7, 21). In contrast, 
because the F′ channel can accommodate an alkyl chain up to 
Figure 7.  Modeling of the effects of variation in lipid chain length 
on the hCD1d structure. In both panels, a Cα trace and selected side 
chains are shown for the hCD1d crystal structure with bound α-GalCer 
(yellow), and relevant regions of the structure of hCD1d in the absence of 
bound ligand are shown in green. Hydrogen bonds are depicted as dotted 
lines. The putative position of bound TCR is indicated schematically. 
(A) The portion of α-GalCer in the crystal structure of hCD1d–α-GalCer, 
which corresponds to OCH9, is drawn in blue. Some side chains are posi-
tioned differently in the empty compared with α-GalCer–fi  lled structure. 
Based on those differences, we have highlighted the residues that are 
predicted to move when OCH9 occupies the F′ channel as compared 
with their position in the α-GalCer–fi  lled F′ channel. (B) The portion of 
α-GalCer that corresponds to a ligand with a shortened acyl chain (C11:1) 
is highlighted in blue. We have highlighted the side chains that are pre-
dicted to shift position based on a comparison of the empty and fully 
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18 carbon atoms long rather than 26 carbon atoms long, F′ 
channel spacer lipids are unlikely to exist when the F′ channel 
is occupied by lipid antigens shorter than 12 carbon atoms 
(such as OCH12 and OCH9) because fatty acids ranging from 
9 to 6 carbon atoms required to fi  ll the remaining unoccupied 
space of the F′ channel comprise only a minor percentage of 
the total fatty acid composition of mammalian cells (24).
We confi  rmed the results obtained using hCD1d mole-
cules coated to the BIAcore chips by developing a FACS-
based assay in which hCD1d molecules were expressed on 
live cells rather than coated to a solid phase (Fig. 2 C). The 
fi  nding that fl  uorescently labeled recombinant iNKT TCR 
tetramers can be used as a staining reagent for GSL-pulsed 
C1R-CD1d cells is of interest because in a previous study, 
the staining of peptide-pulsed target cells by MHC class I–
  restricted TCR could only be obtained using an affi   nity-
  matured TCR with Kd values of  10−12 M (i.e., 106-fold 
higher than the affi   nity values of iNKT TCR; reference 25). 
Because iNKT TCR and wild-type MHC class I–restricted 
TCRs have similar affi   nities, it is tempting to speculate that 
the ability of iNKT TCR to stain GSL-pulsed cells may be 
caused by the clustering of hCD1d–GSL complexes on the 
surface of C1R-hCD1d cells.
Although the role of peptide MHC clustering in TCR 
signaling remains an area of investigation (26), a cooperative 
interaction between mouse CD1d–α-GalCer complexes and 
iNKT TCRs has previously been shown by fl  uorescence res-
onance energy transfer measurements (27). Our fi  nding that 
the FACS-based assays confi  rmed the hierarchy of responses 
to the diff  erent GSLs observed in the SPR results strongly 
suggests that monomeric hCD1d/GSL–TCR interactions 
(i.e., SPR data) are in line with the situation in which the 
physiological multimeric hCD1d/GSL–TCR interactions 
may occur between hCD1d molecules expressed on the sur-
face of APCs and TCRs expressed on iNKT cells. Consistent 
with our data, diff  erences in the ability of mouse iNKT cells 
to be stained by mouse CD1d tetramers loaded with either 
α-GalCer or OCH9 have also been shown (27).
The use of a Fab antibody specifi  c to the hCD1d–α-
galactose–linked sphingolipid complex permitted us to com-
pare the effi   ciency of binding to hCD1d molecules for a 
broad range of α-GalCer analogues. It is of interest that un-
like iNKT TCR, Fab 9B has a more similar affi   nity  for 
hCD1d monomers loaded with either α-GalCer or OCH9 
(unpublished data), suggesting that the footprint of Fab 9B on 
the hCD1d–GSL complex may be diff  erent from the foot-
print of iNKT TCR. We used Fab 9B to study the role of 
each alkyl chain in controlling the rate of dissociation from 
hCD1d molecules. Consistent with previously published data 
with mouse CD1d molecules (28), we demonstrated that the 
shortening of either alkyl chain reduces the stability of the 
hCD1d–lipid complex. We further extended these results by 
demonstrating that the presence of two cis double bonds in 
the acyl chain, at positions 11 and 14 (C20:2; reference 6), 
reduced the rate of dissociation from hCD1d molecules as 
compared with the compound C20:0, which has a saturated 
acyl chain. It is of interest that the compound C20:2, unlike 
the compound C20:0, was shown to be effi   ciently loaded 
onto mouse CD1d molecules lacking an endosomal targeting 
motif, suggesting that the presence of the two double bonds 
at positions 11 and 14 could facilitate its binding to CD1d 
molecules (28). Because the acyl chain of α-GalCer is an-
chored in place in the A′ channel by circumnavigating a 
central pole (4), the observed diff  erences in the rate of disso-
ciation of the C20:0 and C20:2 compounds suggest that a 
preformed kink in the acyl chain caused by the presence of 
the unsaturated bonds may stabilize binding of the lipid by 
favoring the tightly curved conformation required for bind-
ing in the A′ channel.
Our results describe for the fi  rst time the immunological 
synapse of iNKT cells and polarization of iNKT cell cyto-
toxic granules. To determine the eff  ect of the disparity in 
TCR affi   nities and TCR/hCD1d half-lives on the earliest 
events in human iNKT cell synapse formation, we used a 
planar lipid bilayer (15, 29) with constant ICAM-1 density 
and with equal numbers of hCD1d–OCH9 or hCD1d–α-
GalCer complexes. The pattern of segregation of hCD1d 
molecules and ICAM-1 is similar to the pattern described for 
MHC class I– and II–restricted T cells (15). Interestingly, not 
only did the rate of accumulation of hCD1d–GSL complexes 
to cSMAC vary considerably between α-GalCer and OCH9, 
but the fi  nal density of aggregated antigen also diff  ered.
The amount of signal that T cells receive by interacting 
with APCs is determined by several parameters, including the 
concentration of peptide MHC complex (class I peptide 
binding affi   nity) and the duration of the interaction between 
T cells and APCs (TCR binding affi   nity). Previous studies 
have compared the structures of peptide MHC complexes 
with those of altered peptide ligands, for example (30–35). 
Consistent with our fi  ndings describing the role of CD1d-
bound lipid chains in modulating TCR binding affi   nity, these 
comparisons have demonstrated that substitutions of anchor 
residues can cause slight structural alterations that may indi-
rectly impact on TCR recognition, synaptic strength, fl  uxing 
of calcium, and cytokine secretion (35–38).
T cell activation has recently been shown to be initiated 
and sustained in TCR-containing microclusters generated 
at the initial contact sites and at the periphery of the mature 
immunological synapse (39, 40). TCR signaling, which is 
sustained by stabilized microclusters, is terminated in the 
cSMAC, a structure from which TCRs are sorted for degra-
dation (41). After the cSMAC forms, the microclusters con-
tinue to form and are sites of TCR signaling based on the 
recruitment of phosphorylated Lck, ZAP-70, and LAT (39, 
40). Although analysis of microcluster formation in the im-
munological synapse of iNKT cells was beyond the scope of 
this study, our results indicate that the diff  erential rate of ac-
cumulation of hCD1d–GSL complexes to the synapses sub-
stantially correlated with the strength of the subsequent iNKT 
cell stimulation.
When we compared hCD1d–α-GalCer with hCD1d–
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synapses triggered a stronger and more rapid fl  uxing of cal-
cium into the iNKT cells. Thus, the strength of signaling 
through the iNKT cell TCR is far greater for α-GalCer than 
for OCH9, and this determines downstream responses by the 
human iNKT cells. To strengthen these conclusions, we also 
compared the pattern of aggregation in lipid bilayers of 
hCD1d molecules loaded with OCH9 and C20:0 and dem-
onstrated that the pattern and kinetics of hCD1d aggregation 
is very similar to those obtained with hCD1d–α-GalCer 
monomers. OCH9 and C20:0 have a similar rate of dissocia-
tion from hCD1d molecules, strongly suggesting that diff  er-
ences in the iNKT cell TCR affi   nity are controlling the 
pattern of hCD1d clustering in the lipid bilayers. Because 
the comparison of the binding kinetics of iNKT TCR to the 
hCD1d monomers loaded with diff  erent lengths of phyto-
sphingosine chains was as much the result of decreases in the 
kon as increases in the koff  , our results are consistent with pre-
viously published data, demonstrating that the diff  erential 
  accumulation of peptide MHC to cSMAC is ascribed to the 
TCR half-life for the peptide MHC complex (15). A recent 
study by Qi et al. (42) explores this concept further by pro-
viding an algorithm for relating solution half-life to 2D half-
life by incorporating the heat capacity.
Diff  erences in lymphokine profi  les and in the prolifera-
tion of iNKT cells from PBL stimulated with α-GalCer and 
OCH9 can be accounted for by a combined eff  ect of the 
higher affi   nity of α-GalCer to hCD1d molecules and higher 
affi   nity of the iNKT cell TCR for the hCD1d−α-GalCer 
complex. The reduced killing of DCs pulsed with OCH9 as 
compared with the killing of DCs pulsed with α-GalCer is 
consistent with the reduced polarization of cytotoxic gran-
ules in iNKT cells stimulated with weaker agonists. Because 
it has been shown that activation in vivo of iNKT cells can 
assist priming of antigen-specifi  c immune responses (43, 44) 
reduced lysis of DCs pulsed with OCH9 suggests that more 
attention should be focused on the use of weaker iNKT cell 
agonists that, unlike α-GalCer, may ensure a longer life span 
of APCs. This is particularly important because α-GalCer–
pulsed DCs have already been used in clinical trials (45).
In conclusion, our results highlight the eff  ects of variation 
in the length of lipid chains of exogenously loaded lipids oc-
cupying the CD1d F′ channel in fi  ne tuning the affi   nity of 
TCR of hCD1d-restricted lymphocytes. Although further 
experiments are required to extend these fi  ndings to the rec-
ognition of endogenous loaded lipids, our results demonstrate 
that the sensitivity of TCR recognition of hCD1d-restricted 
T lymphocytes can extend to detect diff  erences in lipid chains 
buried in the F′ channel, resulting in altered TCR binding 
kinetics and diff  erent levels of activation signals.
MATERIALS AND METHODS
Reagents and cell lines. GSLs were synthesized by a previously described 
strategy (46), and their structures were confi  rmed by mass spectrometry. 
Glucocerebrosides (Gaucher’s spleen) were purchased from Sigma-Aldrich. 
Human Vα24 iNKT cell lines were generated and maintained as previously 
described (47) in RPMI medium (Sigma-Aldrich).
Protein expression and purifi  cation. hCD1d and β2M protein were 
  refolded with GSL shown in Fig. 1 by oxidative refolding chromatography 
using a protocol that was previously described (48).
Preparation of soluble heterodimeric TCRs. The generation of soluble 
TCR heterodimers was based on the procedure described by Boulter et al. 
(49). In brief, the Vα24 and Vβ11 iNKT cell TCR sequences were ampli-
fi  ed by PCR from the cDNA of an established iNKT cell clone. The α and 
β chains were individually cloned into pGMT7 bacterial expression vectors 
encoding the c-Jun and v-Fos fragments, respectively. TCR chains were ex-
pressed, refolded, and purifi  ed as previously described (49).
Soluble biotinylated TCR was made by inserting a 15–amino acid Avi-
Tag recognition peptide (Avidity) after the c-Jun fragment of the α chain. In 
brief, the α chain Jun fragment was amplifi  ed by PCR and subcloned into a 
pGMT7 vector encoding the AviTag peptide. This new α protein was ex-
pressed, refolded with the β chain, and purifi  ed as before. The TCR hetero-
dimer was biotinylated with BirA enzyme before the fi  nal SD75 gel fi  ltration 
(50). The biotinylated TCR heterodimers were tetramerized by mixing at a 
4:1 molar ratio with Extravidin-PE (Sigma-Aldrich).
SPR. The affi   nity and kinetic properties of Vα24 NKT TCR binding to 
hCD1d–lipid complexes were measured with a spectrometer (model 3000; 
Biacore) as previously described (51). The purifi  ed biotinylated hCD1d–
lipid complexes were immobilized onto streptavidin-coated CM5 sensor 
chips (Biacore) at a level of  1,000 response U. In all experiments, hCD1d–
β-GalCer molecules were used as negative controls. Equilibrium binding 
was performed at a fl  ow rate of 10 μl/min from the lowest TCR concentra-
tion. To exclude any eff  ect of lipid dissociation, which would result in a 
gradual decrease in the level of immobilized CD1d–lipid during the course 
of the experiment, the affi   nity was determined with both increasing (from 
low to highest) and decreasing (from highest to lowest) concentrations of 
TCR. The affi   nity values obtained were not signifi  cantly diff  erent, indicat-
ing that lipid dissociation during the course of the experiments had a negli-
gible eff  ect on the affi   nity measurements. The data was plotted using Origin 
software (OriginLab), and Kd values were calculated using the standard hy-
perbolic model. Kinetics of the TCR–hCD1d/lipid interactions was mea-
sured at 50 μl/min. Equilibrium dissociation constants (Kd) and kon and koff   
were obtained by nonlinear curve fi  tting of the binding curves obtained after 
subtracting the response in the reference fl  ow cells with equations derived 
from the simple 1:1 Langmuir binding model using the BIA evaluation pro-
gram (version 3.02.2; Biacore). SPR was also used to estimate the dissocia-
tion rate of GSL from hCD1d molecules. 1,000 response U of hCD1d 
monomers loaded with either α-GalCer, OCH9, OCH12, OCH15, C20:0, 
C20:2, or C11:1 were immobilized on a streptavidin-coated sensor chip. As 
a negative control, hCD1d–β-GalCer biotinylated monomers were used. 
The amount of hCD1d–GSL remaining at a particular time was measured by 
injecting saturating amounts (30 μl at 500 nM) of Fab 9B antibody.
iNKT TCR tetramer staining. C1R-hCD1d cells were pulsed with 
10 μM, 5 μM, 1 μM, 500 nM, and 100 nM of lipid for 16 h at 37°C and 
washed twice in RPMI. Cells were incubated with iNKT cell TCR tetra-
mers at 37°C for 30 min and washed again twice with ice-cold PBS/1% FCS. 
Samples were analyzed on a fl  ow cytometer (FACSCalibur; BD Biosciences), 
and the data were processed using CellQuest software (BD Biosciences).
Planar lipid bilayers. The GPI-linked ICAM-1 protein was purifi  ed from 
transfected L cells as previously described (52). In brief, the protein was 
solubilized in 1% Triton X-100 buff  er and captured on an anti–ICAM-1 
YN1/1.7 antibody-coupled Sepharose column (N-hydroxysuccinimide–
  activated HiTrap; 1 ml; GE Healthcare). The protein was labeled with Alexa-
Fluor532 (Invitrogen) and eluted at low pH. The purifi  ed, labeled GPI-linked 
ICAM-1 was reconstituted into liposomes by detergent analysis with 0.4 mM 
egg phosphatidylcholine (Avanti Polar Lipids, Inc.). Planar lipid bilayers 
were formed in FCS2 closed chambers as previously described (15). Alexa-
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were mixed with 1,2-dioleocyl-phosphatidylcholine lipids (Avanti Polar 
Lipids, Inc.) at diff  erent ratios to obtain the required molecular densities. 
The chambers were blocked with PBS and 2% FCS. Monobiotinylated 
CD1d monomers were loaded on the bilayers using AlexaFluor633-
  streptavadin (Invitrogen) as a bridging with the biotin lipids. The iNKT cells 
were injected into the 37°C chambers in chamber buff  er (PBS, 0.5% FCS, 
2 mM Mg2+, 0.5 mM Ca2+, and 1 g/liter d-glucose). Confocal fl  uorescence 
and diff  erential interference contrast images were simultaneously obtained at 
specifi  ed times, and iNKT cell contact with the planar bilayer was visualized 
by IRM. Images were acquired on an inverted microscope (Axiovert LSM 
510-META; Carl Zeiss MicroImaging, Inc.) with a 63× oil immersion ob-
jective (Carl Zeiss MicroImaging, Inc.) and analyzed by LSM 510 software 
(Carl Zeiss MicroImaging, Inc.).
Ca2+ infl  ux assays. Intracellular Ca2+ infl  ux was measured by confocal 
  microscopy with a fl  uorometric assay. Cells were labeled with fl  uo-4FF cal-
cium indicator (1 μM in culture medium; Invitrogen) for 30 min at room 
temperature, washed, and injected into the FCS2 closed chamber in cham-
ber buff  er. The Ca2+ fl  ux was monitored by the increase of fl  uorescence 
at  520 nm with an open pinhole to acquire the total signal. The total mean 
fl  uorescence per cell was quantifi  ed as the intensity in the selected cell – 
intensity in the neighboring area at each time point. Data represent the mean 
of 20 cells.
Confocal microscopy. C1R-hCD1d target cells were pulsed with 1 μg/ml, 
100 ng/ml, 10 ng/ml, 1 ng/ml, 100 pg/ml, 10 pg/ml, or 1 pg/ml of either 
α-GalCer or OCH9 lipid for 16 h at 37°C and washed twice in RPMI. 
NKT cells and C1R-hCD1d cells were washed in RPMI, and each cell pel-
let was resuspended to a fi  nal concentration of 106 cells/ml in RPMI. NKT 
cells and targets were mixed 1:1, left for 5 min in suspension, plated on glass 
multiwell slides, and incubated for 20 min at 37°C. Cells were fi  xed in 100% 
methanol precooled to –20°C, washed in PBS, and blocked in PBS/2% BSA 
(Sigma-Aldrich). The cells were stained, and the slides were mounted in PBS 
containing 90% glycerol and 2.5% 1,4-diazabicyclo[2.2.2]octane. Samples 
were examined using a laser-scanning microscope (Radiance 2000 MP; Bio-
Rad Laboratories), and the conjugation rate and granule polarization were 
quantifi  ed using an epifl  uorescent microscope (Axioplan 2; Carl Zeiss 
MicroImaging, Inc.).
DC viability assay. Monocyte-derived DCs were diff  erentiated as de-
scribed previously (53). Immature DCs were collected at day 4, and 30,000 
cells were plated in 96-well fl  at-bottom plates with equal numbers of iNKT 
cells and diff  erent concentrations of lipids. Cells were incubated for 24 h 
before FACS analysis on a fl  ow cytometer (FACSCalibur; BD Biosciences) 
with CellQuest software (BD Biosciences).
ELISA. C1R-hCD1d cells were pulsed for 2 h with GSLs and diluted to 
106cells/ml. 105 cell-pulsed targets were incubated at 37°C with 104 iNKT 
cells in a fi  nal volume of 200 μl. After 18 h, the supernatants were harvested, 
and the concentrations of IFN-γ and IL-4 were determined by ELISA ac-
cording to the manufacturer’s instructions (Mabtech).
iNKT cell expansion. PBMCs were isolated from healthy donors’ buff  y 
coats by density gradient centrifugation over Lymphoprep (Nycomed). 
Monocytes were positively selected using anti-CD14 mAb–coated magnetic 
beads (MACS; Miltenyi Biotec), and monocyte-depleted lymphocyte frac-
tions (CD14 negative) were frozen until needed. Monocytes were cultured 
as previously described with 50 ng/ml GM-CSF (Novartis) and 1,000 U/ml 
IL-4 in six-well plates at 4 × 105 cells/ml (3 ml/well). After 5 d, maturation 
was induced using bacterial LPS (1 μg/ml LPS of Salmonella abortus equi; 
Sigma-Aldrich). Immature and mature monocyte-derived DCs were pheno-
typically analyzed for maturation markers. 2 × 105 monocyte-derived DCs 
were pulsed with GSL for 2 h in 24-well plates in 200 μl RPMI 1640. 2 × 
106 autologous lymphocytes were added in 1.8 ml of medium (5% human 
serum). After 3 d, 25 IU/ml IL-2 was added to cultures. Thereafter, cultures 
were fed every 3–4 d with fresh medium containing 1,000 U/ml IL-2. 
iNKT cell frequencies were determined using APC CD1d tetramer and 
Vα24 antibody (Serotec).
Structural modeling. The structural eff  ects of binding lipid chains of 
various lengths to hCD1d were assessed by comparison of the hCD1d–
α-GalCer and empty hCD1d crystal structures (Protein Data Bank code 
1ZT4). Structural superposition used the Structure Homology Program 
(54), and analysis was performed using the interactive graphics display 
program O (55).
Online supplemental material. Fig. S1 shows iNKT TCR and Fab 9B 
antibody binding to immobilized hCD1d–GSL monomers. hCD1d com-
plexed with α-GalCer, OCH12, OCH9, and β-GalCer were loaded onto a 
streptavidin-coated CM5 sensor chip. Fig. S2 shows equivalent loading of 
the C1R-hCD1d cells with diff  erent GSLs. Video 1 shows the time-lapse 
reconstruction of the kinetics of hCD1d–α-GalCer aggregation (density = 
200 molecules/μm2). Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20062342/DC1.
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